Afterwards, Hurt et al. [9] discovered that CD44+/CD24− prostate cancer cells have the unique ability to grow as nonadherent spheres in serum replacement medium and have the potential to form tumors in NOD/SCID mice. Here, CD44 is linked to prostate carcinoma.